Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
David Lebovitz is an analyst at Citigroup. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/26/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/21/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | 24.93% | David Lebovitz66% | $338 → $351 | Maintains | Buy | Get Alert |
| 02/27/2025 | MDGL | Buy Now | Madrigal Pharmaceuticals | $343.29 | 36.62% | David Lebovitz66% | $378 → $469 | Maintains | Buy | Get Alert |
| 02/20/2025 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.48 | 14.72% | David Lebovitz66% | $81 → $82 | Maintains | Neutral | Get Alert |
| 11/14/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $35.07 | 111.01% | David Lebovitz66% | $70 → $74 | Maintains | Buy | Get Alert |
| 10/30/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.48 | 13.32% | David Lebovitz66% | $93 → $81 | Maintains | Neutral | Get Alert |
| 08/08/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $343.29 | 8.07% | David Lebovitz66% | $382 → $371 | Maintains | Buy | Get Alert |
| 08/02/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | 21.73% | David Lebovitz66% | $291 → $342 | Maintains | Buy | Get Alert |
| 06/25/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | 3.57% | David Lebovitz66% | $227 → $291 | Maintains | Buy | Get Alert |
| 05/09/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $47.06 | -19.25% | David Lebovitz66% | $37 → $38 | Maintains | Buy | Get Alert |
| 05/08/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $343.29 | 11.28% | David Lebovitz66% | $389 → $382 | Maintains | Buy | Get Alert |
| 04/25/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.48 | 27.31% | David Lebovitz66% | $94 → $91 | Maintains | Neutral | Get Alert |
| 03/15/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $343.29 | 13.32% | David Lebovitz66% | $382 → $389 | Maintains | Buy | Get Alert |
| 03/06/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $35.07 | 93.9% | David Lebovitz66% | → $68 | Initiates | → Buy | Get Alert |
| 02/16/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | -19.21% | David Lebovitz66% | $237 → $227 | Maintains | Buy | Get Alert |
| 10/27/2023 | PTCT | Buy Now | PTC Therapeutics | $56.27 | -69.79% | David Lebovitz66% | $29 → $17 | Downgrade | Neutral → Sell | Get Alert |
| 10/10/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | -17.07% | David Lebovitz66% | $266 → $233 | Maintains | Buy | Get Alert |
| 09/18/2023 | PTCT | Buy Now | PTC Therapeutics | $56.27 | -48.46% | David Lebovitz66% | $55 → $29 | Downgrade | Buy → Neutral | Get Alert |
| 08/04/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | -5.32% | David Lebovitz66% | $265 → $266 | Maintains | Buy | Get Alert |
| 05/24/2023 | PTCT | Buy Now | PTC Therapeutics | $56.27 | 11.96% | David Lebovitz66% | $70 → $63 | Maintains | Buy | Get Alert |
| 05/18/2023 | PTCT | Buy Now | PTC Therapeutics | $56.27 | 24.4% | David Lebovitz66% | $67 → $70 | Maintains | Buy | Get Alert |
| 04/28/2023 | PTCT | Buy Now | PTC Therapeutics | $56.27 | 19.07% | David Lebovitz66% | $61 → $67 | Maintains | Buy | Get Alert |
| 02/24/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | -5.68% | David Lebovitz66% | $270 → $265 | Maintains | Buy | Get Alert |
| 02/01/2022 | BPMC | Buy Now | Blueprint Medicines | $94.01 | -2.14% | David Lebovitz66% | $111 → $92 | Maintains | Equal-Weight | Get Alert |
| 10/29/2021 | BPMC | Buy Now | Blueprint Medicines | $94.01 | 18.07% | David Lebovitz66% | $96 → $111 | Maintains | Equal-Weight | Get Alert |
| 08/04/2021 | RYTM | Buy Now | Rhythm Pharmaceuticals | $52.91 | 2.06% | David Lebovitz66% | $57 → $54 | Maintains | Overweight | Get Alert |
| 08/04/2021 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | -16.71% | David Lebovitz66% | $224 → $234 | Maintains | Overweight | Get Alert |
| 07/30/2021 | BPMC | Buy Now | Blueprint Medicines | $94.01 | 2.12% | David Lebovitz66% | $101 → $96 | Maintains | Equal-Weight | Get Alert |
| 07/16/2021 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | -20.27% | David Lebovitz66% | $205 → $224 | Maintains | Overweight | Get Alert |
| 05/14/2021 | AVRO | Buy Now | Avrobio | — | — | David Lebovitz66% | $408 → $372 | Maintains | Overweight | Get Alert |
| 05/07/2021 | EPZM | Buy Now | Epizyme | — | — | David Lebovitz66% | $11 → $10 | Maintains | Equal-Weight | Get Alert |
| 05/06/2021 | IONS | Buy Now | Ionis Pharmaceuticals | $31.52 | 11.05% | David Lebovitz66% | $38 → $35 | Maintains | Underweight | Get Alert |
| 04/30/2021 | MGNX | Buy Now | Macrogenics | $1.84 | 823.91% | David Lebovitz66% | $16 → $17 | Maintains | Underweight | Get Alert |
| 04/30/2021 | BPMC | Buy Now | Blueprint Medicines | $94.01 | 7.44% | David Lebovitz66% | $105 → $101 | Maintains | Equal-Weight | Get Alert |
| 04/30/2021 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | -27.04% | David Lebovitz66% | $206 → $205 | Maintains | Overweight | Get Alert |
| 04/19/2021 | MGNX | Buy Now | Macrogenics | $1.84 | 769.57% | David Lebovitz66% | $15 → $16 | Maintains | Underweight | Get Alert |
| 04/19/2021 | IONS | Buy Now | Ionis Pharmaceuticals | $31.52 | 20.57% | David Lebovitz66% | $43 → $38 | Maintains | Underweight | Get Alert |
| 04/19/2021 | EPZM | Buy Now | Epizyme | — | — | David Lebovitz66% | $14 → $11 | Maintains | Equal-Weight | Get Alert |
| 03/23/2021 | IONS | Buy Now | Ionis Pharmaceuticals | $31.52 | 36.43% | David Lebovitz66% | $50 → $43 | Maintains | Underweight | Get Alert |
| 03/02/2021 | RYTM | Buy Now | Rhythm Pharmaceuticals | $52.91 | 7.73% | David Lebovitz66% | $53 → $57 | Maintains | Overweight | Get Alert |
| 02/26/2021 | MGNX | Buy Now | Macrogenics | $1.84 | 715.22% | David Lebovitz66% | $14 → $15 | Maintains | Underweight | Get Alert |
| 02/25/2021 | IONS | Buy Now | Ionis Pharmaceuticals | $31.52 | 58.64% | David Lebovitz66% | $49 → $50 | Maintains | Underweight | Get Alert |
| 02/25/2021 | EPZM | Buy Now | Epizyme | — | — | David Lebovitz66% | → $14 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/22/2021 | IRWD | Buy Now | Ironwood Pharmaceuticals | $1.50 | 633.33% | David Lebovitz66% | $12 → $11 | Maintains | Equal-Weight | Get Alert |
| 02/19/2021 | IRWD | Buy Now | Ironwood Pharmaceuticals | $1.50 | 633.33% | David Lebovitz66% | $12 → $11 | Maintains | Equal-Weight | Get Alert |
| 02/18/2021 | RYTM | Buy Now | Rhythm Pharmaceuticals | $52.91 | 0.17% | David Lebovitz66% | $33 → $53 | Maintains | Overweight | Get Alert |
| 02/18/2021 | BPMC | Buy Now | Blueprint Medicines | $94.01 | 11.69% | David Lebovitz66% | $112 → $105 | Maintains | Equal-Weight | Get Alert |
| 02/12/2021 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | -26.68% | David Lebovitz66% | $203 → $206 | Maintains | Overweight | Get Alert |
| 02/04/2021 | GWPH | Buy Now | GW Pharmaceuticals | — | — | David Lebovitz66% | $193 → $220 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/07/2020 | NBRV | Buy Now | Nabriva Therapeutics | — | — | David Lebovitz66% | $50 → $500 | Maintains | Equal-Weight | Get Alert |
| 11/25/2020 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | -27.75% | David Lebovitz66% | $200 → $203 | Maintains | Overweight | Get Alert |
| 11/13/2020 | ZEAL | Buy Now | Zealand Pharma | — | — | David Lebovitz66% | $45 → $44 | Maintains | Overweight | Get Alert |
| 11/13/2020 | MGNX | Buy Now | Macrogenics | $1.84 | 660.87% | David Lebovitz66% | $13 → $14 | Maintains | Underweight | Get Alert |
| 11/13/2020 | ASND | Buy Now | Ascendis Pharma | $163.04 | 22.06% | David Lebovitz66% | $194 → $199 | Maintains | Overweight | Get Alert |
| 11/06/2020 | IRWD | Buy Now | Ironwood Pharmaceuticals | $1.50 | 700% | David Lebovitz66% | $11 → $12 | Maintains | Equal-Weight | Get Alert |
| 11/06/2020 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | -28.82% | David Lebovitz66% | $197 → $200 | Maintains | Overweight | Get Alert |
| 11/03/2020 | RYTM | Buy Now | Rhythm Pharmaceuticals | $52.91 | -43.3% | David Lebovitz66% | $31 → $30 | Maintains | Overweight | Get Alert |
| 11/03/2020 | KPTI | Buy Now | Karyopharm Therapeutics | $5.60 | 471.43% | David Lebovitz66% | $510 → $480 | Maintains | Overweight | Get Alert |
| 10/30/2020 | BPMC | Buy Now | Blueprint Medicines | $94.01 | — | David Lebovitz66% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 10/13/2020 | ZEAL | Buy Now | Zealand Pharma | — | — | David Lebovitz66% | $43 → $45 | Maintains | Overweight | Get Alert |
| 10/13/2020 | MGNX | Buy Now | Macrogenics | $1.84 | 606.52% | David Lebovitz66% | $12 → $13 | Maintains | Underweight | Get Alert |
| 10/13/2020 | AVRO | Buy Now | Avrobio | — | — | David Lebovitz66% | $420 → $408 | Maintains | Overweight | Get Alert |
| 10/13/2020 | ASND | Buy Now | Ascendis Pharma | $163.04 | 18.99% | David Lebovitz66% | $179 → $194 | Maintains | Overweight | Get Alert |
| 08/31/2020 | ASND | Buy Now | Ascendis Pharma | $163.04 | 9.79% | David Lebovitz66% | $177 → $179 | Maintains | Overweight | Get Alert |
| 08/14/2020 | ZEAL | Buy Now | Zealand Pharma | — | — | David Lebovitz66% | $40 → $43 | Maintains | Overweight | Get Alert |
| 08/07/2020 | IRWD | Buy Now | Ironwood Pharmaceuticals | $1.50 | 633.33% | David Lebovitz66% | $10 → $11 | Maintains | Equal-Weight | Get Alert |
| 08/07/2020 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | -29.88% | David Lebovitz66% | $199 → $197 | Maintains | Overweight | Get Alert |
| 08/05/2020 | EPZM | Buy Now | Epizyme | — | — | David Lebovitz66% | $31 → $29 | Maintains | Overweight | Get Alert |
| 07/31/2020 | MGNX | Buy Now | Macrogenics | $1.84 | 552.17% | David Lebovitz66% | $11 → $12 | Maintains | Underweight | Get Alert |
| 07/15/2020 | ZEAL | Buy Now | Zealand Pharma | — | — | David Lebovitz66% | $37 → $40 | Maintains | Overweight | Get Alert |
| 07/15/2020 | MGNX | Buy Now | Macrogenics | $1.84 | 497.83% | David Lebovitz66% | $6 → $11 | Maintains | Underweight | Get Alert |
| 07/15/2020 | IRWD | Buy Now | Ironwood Pharmaceuticals | $1.50 | 566.67% | David Lebovitz66% | $11 → $10 | Maintains | Equal-Weight | Get Alert |
| 07/15/2020 | IONS | Buy Now | Ionis Pharmaceuticals | $31.52 | 77.68% | David Lebovitz66% | $51 → $56 | Maintains | Underweight | Get Alert |
| 07/15/2020 | AVRO | Buy Now | Avrobio | — | — | David Lebovitz66% | $444 → $420 | Maintains | Overweight | Get Alert |
| 07/15/2020 | ASND | Buy Now | Ascendis Pharma | $163.04 | 8.56% | David Lebovitz66% | $181 → $177 | Maintains | Overweight | Get Alert |
| 07/15/2020 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | -29.17% | David Lebovitz66% | $162 → $199 | Maintains | Overweight | Get Alert |
| 07/02/2020 | KPTI | Buy Now | Karyopharm Therapeutics | $5.60 | 507.14% | David Lebovitz66% | → $510 | Initiates | → Overweight | Get Alert |
| 06/19/2020 | EPZM | Buy Now | Epizyme | — | — | David Lebovitz66% | $28 → $31 | Maintains | Overweight | Get Alert |
| 05/21/2020 | ASND | Buy Now | Ascendis Pharma | $163.04 | 11.02% | David Lebovitz66% | $180 → $181 | Maintains | Overweight | Get Alert |
| 05/07/2020 | IRWD | Buy Now | Ironwood Pharmaceuticals | $1.50 | 633.33% | David Lebovitz66% | $12 → $11 | Maintains | Equal-Weight | Get Alert |
| 05/07/2020 | IONS | Buy Now | Ionis Pharmaceuticals | $31.52 | 61.81% | David Lebovitz66% | $48 → $51 | Maintains | Underweight | Get Alert |
| 05/07/2020 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | -42.34% | David Lebovitz66% | $148 → $162 | Maintains | Overweight | Get Alert |
| 04/15/2020 | ZEAL | Buy Now | Zealand Pharma | — | — | David Lebovitz66% | $35 → $37 | Maintains | Overweight | Get Alert |
| 04/15/2020 | IRWD | Buy Now | Ironwood Pharmaceuticals | $1.50 | 700% | David Lebovitz66% | $13 → $12 | Maintains | Equal-Weight | Get Alert |
| 04/15/2020 | RYTM | Buy Now | Rhythm Pharmaceuticals | $52.91 | -41.41% | David Lebovitz66% | $33 → $31 | Maintains | Overweight | Get Alert |
| 04/02/2020 | ASND | Buy Now | Ascendis Pharma | $163.04 | 10.4% | David Lebovitz66% | $181 → $180 | Maintains | Overweight | Get Alert |
| 03/31/2020 | AVRO | Buy Now | Avrobio | — | — | David Lebovitz66% | $480 → $444 | Maintains | Overweight | Get Alert |
| 03/31/2020 | ZEAL | Buy Now | Zealand Pharma | — | — | David Lebovitz66% | $38 → $35 | Maintains | Overweight | Get Alert |
| 03/17/2020 | NBRV | Buy Now | Nabriva Therapeutics | — | — | David Lebovitz66% | $1750 → $500 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/26/2020 | ASND | Buy Now | Ascendis Pharma | $163.04 | 11.02% | David Lebovitz66% | $148 → $181 | Maintains | Overweight | Get Alert |
| 02/12/2020 | AVRO | Buy Now | Avrobio | — | — | David Lebovitz66% | $444 → $480 | Maintains | Overweight | Get Alert |
| 02/07/2020 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | -47.32% | David Lebovitz66% | $150 → $148 | Maintains | Overweight | Get Alert |
| 01/17/2020 | ZEAL | Buy Now | Zealand Pharma | — | — | David Lebovitz66% | $35 → $38 | Maintains | Overweight | Get Alert |
| 01/17/2020 | ASND | Buy Now | Ascendis Pharma | $163.04 | -9.22% | David Lebovitz66% | $140 → $148 | Maintains | Overweight | Get Alert |
| 12/17/2019 | ASND | Buy Now | Ascendis Pharma | $163.04 | -14.13% | David Lebovitz66% | $134 → $140 | Maintains | Overweight | Get Alert |
| 12/17/2019 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | -46.61% | David Lebovitz66% | $141 → $150 | Maintains | Overweight | Get Alert |
| 11/21/2019 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | -49.81% | David Lebovitz66% | $124 → $141 | Maintains | Overweight | Get Alert |
| 11/21/2019 | MGNX | Buy Now | Macrogenics | $1.84 | 226.09% | David Lebovitz66% | → $6 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 11/20/2019 | ASND | Buy Now | Ascendis Pharma | $163.04 | -17.81% | David Lebovitz66% | $128 → $134 | Maintains | Overweight | Get Alert |
| 11/15/2019 | ZEAL | Buy Now | Zealand Pharma | — | — | David Lebovitz66% | $30 → $32 | Maintains | Overweight | Get Alert |
| 10/11/2019 | ASND | Buy Now | Ascendis Pharma | $163.04 | -21.49% | David Lebovitz66% | → $128 | Initiates | → Overweight | Get Alert |
| 08/19/2019 | ZEAL | Buy Now | Zealand Pharma | — | — | David Lebovitz66% | $29 → $30 | Maintains | Overweight | Get Alert |
| 08/07/2019 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | -55.87% | David Lebovitz66% | $126 → $124 | Maintains | Overweight | Get Alert |
| 03/05/2019 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | — | David Lebovitz66% | — | Upgrade | Equal-Weight → Overweight | Get Alert |
| 10/11/2018 | GWPH | Buy Now | GW Pharmaceuticals | — | — | David Lebovitz66% | $240 → $227 | Maintains | Overweight | Get Alert |
| 09/28/2018 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | -69.03% | David Lebovitz66% | $93 → $87 | Maintains | Equal-Weight | Get Alert |
| 09/12/2018 | ZEAL | Buy Now | Zealand Pharma | — | — | David Lebovitz66% | → $29 | Reinstates | → Overweight | Get Alert |
| 09/07/2018 | GWPH | Buy Now | GW Pharmaceuticals | — | — | David Lebovitz66% | → $197 | Reinstates | → Overweight | Get Alert |
| 08/13/2018 | CMTA | Buy Now | Clementia Pharmaceuticals | — | — | David Lebovitz66% | $27 → $26 | Maintains | Overweight | Get Alert |
| 08/13/2018 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | -66.9% | David Lebovitz66% | $99 → $93 | Maintains | Equal-Weight | Get Alert |
| 08/03/2018 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | -64.76% | David Lebovitz66% | $107 → $99 | Maintains | Equal-Weight | Get Alert |
| 05/07/2018 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | -61.92% | David Lebovitz66% | $118 → $107 | Maintains | Equal-Weight | Get Alert |
| 03/14/2018 | MGNX | Buy Now | Macrogenics | $1.84 | 1313.04% | David Lebovitz66% | $18 → $26 | Maintains | Equal-Weight | Get Alert |
| 03/06/2018 | AVXS | Buy Now | AveXis | — | — | David Lebovitz66% | $119 → $129 | Maintains | Overweight | Get Alert |
| 02/09/2018 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | -58% | David Lebovitz66% | $128 → $118 | Maintains | Equal-Weight | Get Alert |
| 11/13/2017 | AVXS | Buy Now | AveXis | — | — | David Lebovitz66% | $118 → $120 | Maintains | Overweight | Get Alert |
| 11/09/2017 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | -53.73% | David Lebovitz66% | $101 → $130 | Maintains | Equal-Weight | Get Alert |
| 09/21/2017 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | -64.05% | David Lebovitz66% | $50 → $101 | Maintains | Equal-Weight | Get Alert |
| 08/28/2017 | CMTA | Buy Now | Clementia Pharmaceuticals Inc. - Common Shares | — | — | David Lebovitz66% | → $27 | Initiates | → Overweight | Get Alert |
| 08/10/2017 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | -82.2% | David Lebovitz66% | $46 → $50 | Maintains | Equal-Weight | Get Alert |
| 08/07/2017 | MGNX | Buy Now | Macrogenics | $1.84 | 1041.3% | David Lebovitz66% | $22 → $21 | Maintains | Equal-Weight | Get Alert |
| 08/03/2017 | AVXS | Buy Now | AveXis | — | — | David Lebovitz66% | → $118 | Initiates | → Overweight | Get Alert |
| 07/10/2017 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | -83.63% | David Lebovitz66% | $42 → $46 | Maintains | Equal-Weight | Get Alert |
| 10/07/2016 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | — | David Lebovitz66% | — | Downgrade | Overweight → Equal-weight | Get Alert |
| 09/27/2016 | GWPH | Buy Now | GW Pharmaceuticals | — | — | David Lebovitz66% | $152 → $160 | Maintains | Overweight | Get Alert |
| 02/25/2016 | MGNX | Buy Now | Macrogenics | $1.84 | 986.96% | David Lebovitz66% | → $20 | Initiates | → Equal-Weight | Get Alert |
| 08/13/2015 | GWPH | Buy Now | GW Pharmaceuticals | — | — | David Lebovitz66% | → $150 | Initiates | → Overweight | Get Alert |
| 04/22/2014 | GWPH | Buy Now | GW Pharmaceuticals | — | — | David Lebovitz66% | → $103 | Initiates | → Overweight | Get Alert |
